Martha M Tarpay, MD | |
4200 W Memorial Rd, Suite 206, Oklahoma City, OK 73120-9350 | |
(405) 752-0393 | |
(405) 752-4242 |
Full Name | Martha M Tarpay |
---|---|
Gender | Female |
Speciality | Allergy/immunology |
Experience | 59 Years |
Location | 4200 W Memorial Rd, Oklahoma City, Oklahoma |
Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306808928 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207KA0200X | Allergy & Immunology - Allergy | 10144 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
Mailing Address | Practice Location Address |
---|---|
Martha M Tarpay, MD 4200 W Memorial Rd, Suite 206, Oklahoma City, OK 73120-9350 Ph: (405) 752-0393 | Martha M Tarpay, MD 4200 W Memorial Rd, Suite 206, Oklahoma City, OK 73120-9350 Ph: (405) 752-0393 |
News Archive
John DeVincenzo, MD, professor and researcher in the Departments of Pediatrics and Molecular Sciences at the University of Tennessee Health Science Center (UTHSC), has proven for the first time that a totally new concept in drug design can be used to treat human disease. Dr. DeVincenzo, who also serves as a children's infectious diseases specialist at Le Bonheur Children's Hospital, conducted his study at the Children's Foundation Research Center, a UT Health Science Center partner located at Le Bonheur.
The University of Oxford have begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers - with the first vaccinations taking place today (Thursday, 11 November).
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has entered into definitive agreements for the purchase of $50.1 million of Achillion's common stock and warrants in a private placement financing with a select group of institutional and accredited investors, namely Domain Associates, Clarus Ventures, Quaker BioVentures and Pappas Ventures.
Regeneron Pharmaceuticals, Inc. and the Colorado Center for Personalized Medicine at the University of Colorado Anschutz Medical Campus today announced a large-scale research collaboration designed to advance the field of human genetics and precision medicine through the sharing of 450,000 DNA samples and corresponding health records from de-identified, consented patient participants in the expansive UCHealth system.
› Verified 1 days ago
Dr. Patricia Ingham Overhulser, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 750 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-235-0040 | |
Ira N Targoff, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 825 Ne 10th St, Oupb 2300, Oklahoma City, OK 73104 Phone: 405-271-8478 Fax: 405-271-4230 | |
Dr. Amy L. Darter, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1810 E Memorial Rd, Oklahoma City, OK 73131 Phone: 405-607-4333 Fax: 405-607-4404 | |
Dr. Dean Alan Atkinson, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 750 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-235-0040 Fax: 405-235-4495 | |
Dr. James Howard Wells, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 750 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-235-0040 Fax: 405-235-4495 | |
Dr. John Russell Bozalis, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 750 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-235-0040 Fax: 405-235-4495 |